MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0000000000013139

Медицинская библиотека · Neurology · 2021

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Doets Alex Y, Lingsma Hester F, Walgaard Christa, Islam Badrul, Papri Nowshin, Davidson Amy, Yamagishi Yuko, Kusunoki Susumu, Dimachkie Mazen M, Waheed Waqar, Kolb Noah, Islam Zhahirul, Mohammad Quazi Deen, Harbo Thomas, Sindrup Soren H, Chavada Govindsinh, Willison Hugh J, Casasnovas Carlos, Bateman Kathleen, Miller James A L, van den Berg Bianca, Verboon Christine, Roodbol Joyce, Leonhard Sonja E, Benedetti Luana, Kuwabara Satoshi, Van den Bergh Peter, Monges Soledad, Marfia Girolama A, Shahrizaila Nortina, Galassi Giuliana, Péréon Yann, Bürmann Jan, Kuitwaard Krista, Kleyweg Ruud P, Marchesoni Cintia, Sedano Tous María J, Querol Luis, Illa Isabel, Wang Yuzhong, Nobile-Orazio Eduardo, Rinaldi Simon, Schenone Angelo, Pardo Julio, Vermeij Frederique H, Lehmann Helmar C, Granit Volkan, Cavaletti Guido, Gutiérrez-Gutiérrez Gerardo, Barroso Fabio A, Visser Leo H, Katzberg Hans D, Dardiotis Efthimios, Attarian Shahram, van der Kooi Anneke J, Eftimov Filip, Wirtz Paul W, Samijn Johnny P A, Gilhuis H Jacobus, Hadden Robert D M, Holt James K L, Sheikh Kazim A, Karafiath Summer, Vytopil Michal, Antonini Giovanni, Feasby Thomas E, Faber Catharina G, Gijsbers Cees J, Busby Mark, Roberts Rhys C, Silvestri Nicholas J, Fazio Raffaella, van Dijk Gert W, Garssen Marcel P J, Straathof Chiara S M, Gorson Kenneth C, Jacobs Bart C, IGOS Consortium

СтатьяПоддержка исследования: вне правительства СШАНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVES

The clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed with data from Dutch patients, is a clinical model that predicts the risk of walking inability in patients with GBS. The study objective was to validate the mEGOS in the International GBS Outcome Study (IGOS) cohort and to improve its performance and region specificity.

METHODS

We used prospective data from the first 1,500 patients included in IGOS, aged ≥6 years and unable to walk independently. We evaluated whether the mEGOS at entry and week 1 could predict the inability to walk unaided at 4 and 26 weeks in the full cohort and in regional subgroups, using 2 measures for model performance: (1) discrimination: area under the receiver operating characteristic curve (AUC) and (2) calibration: observed vs predicted probability of being unable to walk independently. To improve the model predictions, we recalibrated the model containing the overall mEGOS score, without changing the individual predictive factors. Finally, we assessed the predictive ability of the individual factors.

RESULTS

For validation of mEGOS at entry, 809 patients were eligible (Europe/North America [n = 677], Asia [n = 76], other [n = 56]), and 671 for validation of mEGOS at week 1 (Europe/North America [n = 563], Asia [n = 65], other [n = 43]). AUC values were >0.7 in all regional subgroups. In the Europe/North America subgroup, observed outcomes were worse than predicted; in Asia, observed outcomes were better than predicted. Recalibration improved model accuracy and enabled the development of a region-specific version for Europe/North America (mEGOS-Eu/NA). Similar to the original mEGOS, severe limb weakness and higher age were the predominant predictors of poor outcome in the IGOS cohort.

DISCUSSION: mEGOS is a validated tool to predict the inability to walk unaided at 4 and 26 weeks in patients with GBS, also in countries outside the Netherlands. We developed a region-specific version of mEGOS for patients from Europe/North America.

CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the mEGOS accurately predicts the inability to walk unaided at 4 and 26 weeks in patients with GBS.

TRIAL REGISTRATION INFORMATION: NCT01582763.

Для цитирования: Doets Alex Y, Lingsma Hester F, Walgaard Christa, Islam Badrul, Papri Nowshin, Davidson Amy, Yamagishi Yuko, Kusunoki Susumu, Dimachkie Mazen M, Waheed Waqar, Kolb Noah, Islam Zhahirul, Mohammad Quazi Deen, Harbo Thomas, Sindrup Soren H, Chavada Govindsinh, Willison Hugh J, Casasnovas Carlos, Bateman Kathleen, Miller James A L, van den Berg Bianca, Verboon Christine, Roodbol Joyce, Leonhard Sonja E, Benedetti Luana, Kuwabara Satoshi, Van den Bergh Peter, Monges Soledad, Marfia Girolama A, Shahrizaila Nortina, Galassi Giuliana, Péréon Yann, Bürmann Jan, Kuitwaard Krista, Kleyweg Ruud P, Marchesoni Cintia, Sedano Tous María J, Querol Luis, Illa Isabel, Wang Yuzhong, Nobile-Orazio Eduardo, Rinaldi Simon, Schenone Angelo, Pardo Julio, Vermeij Frederique H, Lehmann Helmar C, Granit Volkan, Cavaletti Guido, Gutiérrez-Gutiérrez Gerardo, Barroso Fabio A, Visser Leo H, Katzberg Hans D, Dardiotis Efthimios, Attarian Shahram, van der Kooi Anneke J, Eftimov Filip, Wirtz Paul W, Samijn Johnny P A, Gilhuis H Jacobus, Hadden Robert D M, Holt James K L, Sheikh Kazim A, Karafiath Summer, Vytopil Michal, Antonini Giovanni, Feasby Thomas E, Faber Catharina G, Gijsbers Cees J, Busby Mark, Roberts Rhys C, Silvestri Nicholas J, Fazio Raffaella, van Dijk Gert W, Garssen Marcel P J, Straathof Chiara S M, Gorson Kenneth C, Jacobs Bart C, IGOS Consortium. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.. Neurology. 2021. DOI: 10.1212/wnl.0000000000013139.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.